Sanofi Aventis deny ImClone bid

Posted on May 14, 2008 in Antibiotic (Category: Default)

Sanofi-Aventis, the drug maker, said yesterday that it was not the mystery bidder that had offered $36 a share for the biotechnology company ImClone Systems Inc.

Original article: Sanofi Aventis deny ImClone bid

Tags: , , , ,

Search